STATE STREET CORP, a registered investment adviser, initiated a new position in Pfizer Inc. (NYSE:PFE) during Q4 2025, according to its most recent 13F filing with the Securities…
STATE STREET CORP, a registered investment adviser, initiated a new position in Pfizer Inc. (NYSE:PFE) during Q4 2025, according to its most recent 13F filing with the Securities and Exchange Commission.
The institutional investor purchased 300,445,164 shares of the Healthcare company, valued at approximately $7.5B as of the filing date.
Pfizer Inc.'s stock currently trades at $27.80 with a market capitalization of $146.7B.
Current market data
NYSE · PFE
$27.96
Down: -$0.06 · -0.21%
Live quote updated
Our Markets Team monitors market data, SEC filings, analyst actions, earnings releases, and corporate announcements to produce timely updates for investors.
Keep reading
